News Archives

News

October 18, 2021

Vivos Therapeutics and Candid Announce Strategic Collaboration to Deliver A Comprehensive Sleep Apnea and Orthodontic Treatment Solution

Vivos Therapeutics and Candid Announce Strategic Collaboration to Deliver A Comprehensive Sleep Apnea and Orthodontic…

Grant Smith

News

October 13, 2021

Children in Latest Clinical Study Show Significant Reduction of Tooth Decay After Treatment With Vivos Guides

Children in Latest Clinical Study Show Significant Reduction of Tooth Decay After Treatment With Vivos…

Grant Smith

News

September 23, 2021

Vivos Therapeutics Announces Formation of New Medical Consortium to Advance the Company’s Technology for Obstructive Sleep Apnea

Vivos Therapeutics Announces Formation of New Medical Consortium to Advance the Company’s Technology for Obstructive…

Osmond Marketing

News

September 22, 2021

Vivos Therapeutics to Participate at the Benzinga Healthcare Small Cap Conference

Vivos Therapeutics to Participate at the Benzinga Healthcare Small Cap Conference Vivos management to present…

Osmond Marketing

News

September 8, 2021

Vivos Therapeutics to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference

Vivos Therapeutics to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference Vivos management…

Osmond Marketing

News

August 26, 2021

Vivos Therapeutics and Empower Sleep Launch Cooperative Relationship Aimed at Significantly Improving Proper Obstructive Sleep Apnea Diagnosis and Treatment

Vivos Therapeutics and Empower Sleep Launch Cooperative Relationship Aimed at Significantly Improving Proper Obstructive Sleep…

Osmond Marketing

News

August 23, 2021

FDA Grants 510(k) Market Clearance to Vivos Therapeutics’ mmRNA Oral Appliance for Treating Mild to Moderate Sleep Apnea

FDA Grants 510(k) Market Clearance to Vivos Therapeutics’ mmRNA Oral Appliance for Treating Mild to…

Osmond Marketing

News

August 17, 2021

Detailed Summary of Study Reporting that One in Four Patients Show No Symptoms of Obstructive Sleep Apnea After Vivos Treatment Now Available on Vivos Therapeutics Website

Detailed Summary of Study Reporting that One in Four Patients Show No Symptoms of Obstructive…

Osmond Marketing

News

August 12, 2021

Vivos Therapeutics Reports Second Quarter 2021 Financial Results and Operational Update

Vivos Therapeutics Reports Second Quarter 2021 Financial Results and Operational Update Second Quarter Revenue Increased…

Osmond Marketing

News

August 9, 2021

Vivos Therapeutics to Participate at the Q3 Virtual Investor Summit

Vivos Therapeutics to Participate at the Q3 Virtual Investor Summit Vivos management to present at…

Osmond Marketing

News

Vivos Therapeutics and Candid Announce Strategic Collaboration to Deliver A Comprehensive Sleep Apnea and Orthodontic Treatment Solution

Children in Latest Clinical Study Show Significant Reduction of Tooth Decay After Treatment With Vivos Guides

Vivos Therapeutics Announces Formation of New Medical Consortium to Advance the Company’s Technology for Obstructive Sleep Apnea

Vivos Therapeutics to Participate at the Benzinga Healthcare Small Cap Conference

Vivos Therapeutics to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference

Vivos Therapeutics and Empower Sleep Launch Cooperative Relationship Aimed at Significantly Improving Proper Obstructive Sleep Apnea Diagnosis and Treatment

FDA Grants 510(k) Market Clearance to Vivos Therapeutics’ mmRNA Oral Appliance for Treating Mild to Moderate Sleep Apnea

Detailed Summary of Study Reporting that One in Four Patients Show No Symptoms of Obstructive Sleep Apnea After Vivos Treatment Now Available on Vivos Therapeutics Website

Vivos Therapeutics Reports Second Quarter 2021 Financial Results and Operational Update

Vivos Therapeutics to Participate at the Q3 Virtual Investor Summit

About Vivos

Explore Vivos

Corporate Information

Stay Connected